Lipovisc

Carbomer, the active ingredient in Lipovisc, is an excipient presented as a viscosity‑enhancing agent for ocular administration. It increases the thickness of eye drops, helping the solution remain on the ocular surface longer, which can improve drug residence time and patient comfort.

GNH USA supplies Lipovisc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable logistics and responsive technical support.

Lipovisc, a carbomer‑based ophthalmic viscosity agent, is employed to improve ocular surface retention in various eye‑care applications. - Dry eye syndrome: prolongs residence time of lubricating drops, enhancing ocular surface hydration. - Post‑operative eye care: maintains therapeutic eye drop contact after surgery, supporting healing. - Ocular surface disease: increases viscosity of medicated solutions to improve drug delivery to the cornea and conjunctiva. - Contact lens discomfort: provides a thicker formulation that reduces irritation.

Carbomer may cause local ocular reactions, most of which are mild and transient.

Common Side Effects: - Eye irritation: mild burning or stinging upon instillation. - Redness: temporary conjunctival hyperemia. - Blurred vision: short‑term visual disturbance that resolves quickly. - Tearing: increased lacrimation after application. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Allergic reaction: swelling, itching, or rash requiring medical attention. - Corneal ulceration: persistent ulcer formation needing urgent care. - Severe inflammation: marked uveitis or keratitis. - Vision loss: sudden decrease in visual acuity. - Anaphylaxis: systemic hypersensitivity reaction (extremely rare).

When using Lipovisc, consider the following precautions to ensure safety and efficacy. - Patient history: assess for known hypersensitivity to carbomer or similar polymers. - Concomitant eye drops: avoid mixing with other ophthalmic solutions unless compatibility is confirmed. - Contact lens wear: remove lenses before instillation and wait before reinserting. - Ocular infection: defer use if active infection is present until treated. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Carbomer can interact physically or chemically with certain ophthalmic products, which may affect formulation stability or ocular tolerance.

Major Interactions (Avoid): - Preservative incompatibility: carbomer may precipitate with high concentrations of benzalkonium chloride. - Acidic eye drops: low pH formulations can cause gel destabilization. - Anticholinergic eye drops: may reduce carbomer’s viscosity‑enhancing effect.

Moderate Interactions (Monitor Closely): - Other polymers: co‑administration with hyaluronic acid may alter viscosity profile. - Topical antibiotics: monitor for increased irritation. - Anti‑inflammatory drops: assess for any change in drug absorption.